Aplasia cutis congenita after methimazole exposure in utero successfully treated with basic fibroblast growth factor.
Abe
Masatoshi
M
Syuto
Tomoko
T
Yokoyama
Yoko
Y
Ishikawa
Osamu
O
D013956:Antithyroid Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004476:Ectodermal Dysplasia / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D016222:Fibroblast Growth Factor 2 / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D008713:Methimazole / Q000008:administration & dosage / Q000009:adverse effects*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy*; D012883:Skin Ulcer / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy*
D013956:Antithyroid Agents; D016222:Fibroblast Growth Factor 2; D008713:Methimazole